Wells Fargo’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461 | Sell |
|
|||||
|
2025
Q1 | $54.8K | Buy |
|
|||||
|
2024
Q4 | $57.2K | Buy |
|
|||||
|
2024
Q3 | $67.3K | Buy |
|
|||||
|
2024
Q2 | $62.7K | Buy |
|
|||||
|
2024
Q1 | $2.01K | Buy |
|
|||||
|
2023
Q4 | $735 | Sell |
|
|||||
|
2023
Q3 | $2.91K | Buy |
|
|||||
|
2023
Q2 | $1.07K | Buy |
|
|||||
|
2023
Q1 | $460 | Buy |
|
|||||
|
2022
Q4 | $366 | Buy |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $11K | Sell |
|
|||||
|
2021
Q4 | $69K | Buy |
|
|||||
|
2021
Q3 | $0 | Sell |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $126K | Sell |
|
|||||
|
2020
Q4 | $848K | Buy |
|
|||||
|
2020
Q3 | $467K | Sell |
|
|||||
|
2020
Q2 | $1.02M | Buy |
|
|||||
|
2020
Q1 | $343K | Sell |
|
|||||
|
2019
Q4 | $2.47M | Buy |
|
|||||
|
2019
Q3 | $150K | Buy |
|
|||||
|
2019
Q2 | $322K | Sell |
|
|||||
|
2019
Q1 | $157K | Buy |
|
|||||
|
2018
Q4 | $91K | Sell |
|
|||||
|
2018
Q3 | $206K | Buy |
|
|||||
|
2018
Q2 | $67K | Buy |
|
|||||
|
2018
Q1 | $35K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $39K | Sell |
|
|||||
|
2016
Q4 | $163K | Buy |
|
|||||
|
2016
Q3 | $59K | Hold |
|
|||||
|
2016
Q2 | $46K | Buy |
|
|||||
|
2016
Q1 | $20K | Buy |
|
|||||
|
2015
Q4 | $30K | Sell |
|
|||||
|
2015
Q3 | $31K | Buy |
|
|||||
|
2015
Q2 | $58K | Sell |
|
|||||
|
2015
Q1 | $329K | Buy |
|
|||||
|
2014
Q4 | $17K | Buy |
|